Mitochondrial dysfunction–ferroptosis crosstalk drives bone remodeling imbalance in osteoporosis: mechanisms and recent advances
Osteoporosis is a highly prevalent metabolic bone disease worldwide, and its central pathological mechanism is an imbalance in bone remodeling. Mitochondrial dysfunction and ferroptosis, two key mechanisms of cellular injury, have recently been shown to jointly drive the onset and progression of osteoporosis through complex crosstalk networks. Mitochondrial dysfunction is characterized by abnormal mitochondrial dynamics, impaired oxidative phosphorylation, and defective mitophagy, whereas ferroptosis is defined by iron overload, lipid peroxidation, and glutathione peroxidase 4 (GPX4) inactivation. These processes interact in osteoblasts, osteoclasts, and osteocytes. Reactive oxygen species (ROS) signaling, iron metabolic disorder, and the mitochondria–endoplasmic reticulum stress axis play central roles in bone remodeling imbalance by coordinately regulating cell fate and bone metabolic homeostasis. This narrative review provides a structured synthesis of recent advances in the crosstalk between mitochondrial dysfunction and ferroptosis, integrating evidence from molecular biology, cell biology, animal models, and selected clinical observations. The aim is to provide a theoretical basis and identify potential intervention targets for the development of targeted therapies for osteoporosis.
Authors
- 江育琴
- Lianlin Zeng (ORCID: https://orcid.org/0009-0000-9905-5201)
- Yu Lin
- Haixu Chen
- Liangfang Cai
- Xia Liu
Institutions
- Tongren University (CN)
- Zigong First People's Hospital (CN)
- Guizhou Health Vocational College (CN)
- Sichuan Vocational College of Health and Rehabilitation (CN)
Publication Details
- Journal
- Frontiers in Physiology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fphys.2026.1968012
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00